Literature DB >> 11086074

The expression of MHC class II genes in macrophages is cell cycle dependent.

J Xaus1, M Comalada, M Barrachina, C Herrero, E Goñalons, C Soler, J Lloberas, A Celada.   

Abstract

Using different drugs, we stopped the cell cycle of bone marrow-derived macrophages at different points. After IFN-gamma stimulation, macrophages arrested at the G(1) phase of the cell cycle did not increase cell surface expression of the MHC class II IA. This inhibition is specific, because, under the same conditions, IFN-gamma induces the expression of Fcgamma receptors and the inducible NO synthase mRNA. Treatments that inhibit macrophage proliferation by blocking the cell cycle at the G(1) phase, such as adenosine, forskolin, or LPS, blocked the IFN-gamma induction of IA. Under IFN-gamma treatment, the steady-state levels of IAalpha and IAss mRNA did not increase in cells arrested at the G(1) phase and the half-life of the MHC mRNA was not modified. These data suggest that the cell cycle modulation of IFN-gamma-induced MHC II gene expression occurs at the transcriptional level. The expression of the class II transactivator mRNA induced by IFN-gamma was also blocked when macrophages were arrested at the G(1) phase of the cell cycle, suggesting that the lack of IFN-gamma response occurs at the early steps of MHC class II expression. Finally, macrophages arrested at the G(1) phase showed increased basal levels of cell surface IA due to an increase of the translational efficiency. These data show that the expression of MHC class II genes is regulated by the cell cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086074     DOI: 10.4049/jimmunol.165.11.6364

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  16 in total

1.  Immune dysfunctionality of replicative senescent mesenchymal stromal cells is corrected by IFNγ priming.

Authors:  Raghavan Chinnadurai; Devi Rajan; Spencer Ng; Kenneth McCullough; Dalia Arafat; Edmund K Waller; Larry J Anderson; Greg Gibson; Jacques Galipeau
Journal:  Blood Adv       Date:  2017-04-25

2.  Phagocytic efficacy of macrophage-like cells as a function of cell cycle and Fcgamma receptors (FcgammaR) and complement receptor (CR)3 expression.

Authors:  Y Luo; E Cook; B C Fries; A Casadevall
Journal:  Clin Exp Immunol       Date:  2006-08       Impact factor: 4.330

3.  Analysis of cell cycle and replication of mouse macrophages after in vivo and in vitro Cryptococcus neoformans infection using laser scanning cytometry.

Authors:  Carolina Coelho; Lydia Tesfa; Jinghang Zhang; Johanna Rivera; Teresa Gonçalves; Arturo Casadevall
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

4.  Francisella tularensis induces ubiquitin-dependent major histocompatibility complex class II degradation in activated macrophages.

Authors:  Justin E Wilson; Bhuvana Katkere; James R Drake
Journal:  Infect Immun       Date:  2009-08-24       Impact factor: 3.441

Review 5.  Thymus and aging: morphological, radiological, and functional overview.

Authors:  Rita Rezzani; Lorenzo Nardo; Gaia Favero; Michele Peroni; Luigi Fabrizio Rodella
Journal:  Age (Dordr)       Date:  2013-07-23

6.  Innate immune responses to cytomegalovirus infection in the developing mouse brain and their evasion by virus-infected neurons.

Authors:  Isao Kosugi; Hideya Kawasaki; Yoshifumi Arai; Yoshihiro Tsutsui
Journal:  Am J Pathol       Date:  2002-09       Impact factor: 4.307

7.  Effect of Source Animal Age upon Macrophage Response to Extracellular Matrix Biomaterials.

Authors:  Samuel T LoPresti; Bryan N Brown
Journal:  J Immunol Regen Med       Date:  2018-04-25

8.  Enhanced single-cell RNA-seq workflow reveals coronary artery disease cellular cross-talk and candidate drug targets.

Authors:  Wei Feng Ma; Chani J Hodonsky; Adam W Turner; Doris Wong; Yipei Song; Jose Verdezoto Mosquera; Alexandra V Ligay; Lotte Slenders; Christina Gancayco; Huize Pan; Nelson B Barrientos; David Mai; Gabriel F Alencar; Katherine Owsiany; Gary K Owens; Muredach P Reilly; Mingyao Li; Gerard Pasterkamp; Michal Mokry; Sander W van der Laan; Bohdan B Khomtchouk; Clint L Miller
Journal:  Atherosclerosis       Date:  2021-11-26       Impact factor: 5.162

9.  Impaired macrophage trafficking and increased helper T-cell recruitment with loss of cadherin-11 in atherosclerotic immune response.

Authors:  Camryn L Johnson; Lance Riley; Matthew Bersi; MacRae F Linton; W David Merryman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-09-10       Impact factor: 5.125

10.  Adoptive transfer of M2 macrophages reduces neuropathic pain via opioid peptides.

Authors:  Maria Pannell; Dominika Labuz; Melih Ö Celik; Jacqueline Keye; Arvind Batra; Britta Siegmund; Halina Machelska
Journal:  J Neuroinflammation       Date:  2016-10-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.